Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	voltage-gated sodium channel activity	NALCN SCN1A SCN2A SCN3A CACNA1H	1.43e-06	26	153	5	GO:0005248
GeneOntologyMolecularFunction	alkali metal ion binding	CPS1 SCN1A SCN2A SCN3A	4.34e-05	26	153	4	GO:0031420
GeneOntologyMolecularFunction	sodium channel activity	NALCN SCN1A SCN2A SCN3A CACNA1H	4.81e-05	52	153	5	GO:0005272
GeneOntologyMolecularFunction	channel activity	CACNA1C CACNA1F CACNA2D2 GRID1 RYR2 RYR3 NALCN SCN1A SCN2A SCN3A TMEM150C CACNA1H GJC3 GABRR3	5.37e-05	525	153	14	GO:0015267
GeneOntologyMolecularFunction	monoatomic ion channel activity	CACNA1C CACNA1F CACNA2D2 GRID1 RYR2 RYR3 NALCN SCN1A SCN2A SCN3A TMEM150C CACNA1H GABRR3	5.46e-05	459	153	13	GO:0005216
GeneOntologyMolecularFunction	passive transmembrane transporter activity	CACNA1C CACNA1F CACNA2D2 GRID1 RYR2 RYR3 NALCN SCN1A SCN2A SCN3A TMEM150C CACNA1H GJC3 GABRR3	5.48e-05	526	153	14	GO:0022803
GeneOntologyMolecularFunction	gated channel activity	CACNA1C CACNA1F CACNA2D2 GRID1 RYR2 RYR3 SCN1A SCN2A TMEM150C CACNA1H GABRR3	5.49e-05	334	153	11	GO:0022836
GeneOntologyMolecularFunction	sodium ion binding	SCN1A SCN2A SCN3A	1.51e-04	14	153	3	GO:0031402
GeneOntologyMolecularFunction	high voltage-gated calcium channel activity	CACNA1C CACNA1F CACNA1H	1.51e-04	14	153	3	GO:0008331
GeneOntologyMolecularFunction	monoatomic cation channel activity	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 NALCN SCN1A SCN2A SCN3A CACNA1H	3.22e-04	343	153	10	GO:0005261
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR2 RYR3	3.46e-04	4	153	2	GO:0005219
GeneOntologyMolecularFunction	demethylase activity	CYP1A1 CYP1A2 KDM5B RIOX1	3.54e-04	44	153	4	GO:0032451
GeneOntologyMolecularFunction	voltage-gated calcium channel activity	CACNA1C CACNA1F CACNA2D2 CACNA1H	4.21e-04	46	153	4	GO:0005245
GeneOntologyMolecularFunction	calcium channel activity	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	4.81e-04	129	153	6	GO:0005262
GeneOntologyMolecularFunction	keratin filament binding	VIM EPPK1	8.57e-04	6	153	2	GO:1990254
GeneOntologyMolecularFunction	histone H3K4me/H3K4me2/H3K4me3 demethylase activity	KDM5B RIOX1	8.57e-04	6	153	2	GO:0034647
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR2 RYR3	8.57e-04	6	153	2	GO:0048763
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	1.10e-03	151	153	6	GO:0015085
GeneOntologyMolecularFunction	hydroperoxy icosatetraenoate dehydratase activity	CYP1A1 CYP1A2	1.19e-03	7	153	2	GO:0106256
GeneOntologyMolecularFunction	2-oxoglutarate-dependent dioxygenase activity	KDM5B JMJD4 RIOX1 ALKBH6	1.56e-03	65	153	4	GO:0016706
GeneOntologyMolecularFunction	histone H3K4 demethylase activity	KDM5B RIOX1	1.58e-03	8	153	2	GO:0032453
GeneOntologyMolecularFunction	estrogen 2-hydroxylase activity	CYP1A1 CYP1A2	1.58e-03	8	153	2	GO:0101021
GeneOntologyMolecularFunction	calmodulin binding	MYO1G CACNA1C OBSCN RYR2 RYR3 SCN2A SCN3A	2.01e-03	230	153	7	GO:0005516
GeneOntologyBiologicalProcess	membrane depolarization during action potential	CACNA1C SCN1A SCN2A SCN3A CACNA1H	6.80e-06	36	154	5	GO:0086010
GeneOntologyCellularComponent	mitochondrial nucleoid	SHMT2 TWNK CPS1 ATAD3C ATAD3A DDX28	2.06e-06	51	155	6	GO:0042645
GeneOntologyCellularComponent	nucleoid	SHMT2 TWNK CPS1 ATAD3C ATAD3A DDX28	2.06e-06	51	155	6	GO:0009295
GeneOntologyCellularComponent	voltage-gated sodium channel complex	SCN1A SCN2A SCN3A CACNA1H	6.42e-06	17	155	4	GO:0001518
GeneOntologyCellularComponent	calcium channel complex	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	1.70e-05	73	155	6	GO:0034704
GeneOntologyCellularComponent	sodium channel complex	SCN1A SCN2A SCN3A CACNA1H	5.98e-05	29	155	4	GO:0034706
GeneOntologyCellularComponent	cation channel complex	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 SCN1A SCN2A SCN3A CACNA1H	6.67e-05	235	155	9	GO:0034703
GeneOntologyCellularComponent	sarcolemma	CACNA1C OBSCN POPDC2 RYR2 RYR3 SCN1A SCN2A CACNA1H	8.86e-05	190	155	8	GO:0042383
GeneOntologyCellularComponent	monoatomic ion channel complex	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 NALCN SCN1A SCN2A SCN3A CACNA1H GABRR3	1.24e-04	378	155	11	GO:0034702
GeneOntologyCellularComponent	AP-5 adaptor complex	AP5S1 AP5Z1	3.25e-04	4	155	2	GO:0044599
GeneOntologyCellularComponent	voltage-gated calcium channel complex	CACNA1C CACNA1F CACNA2D2 CACNA1H	3.72e-04	46	155	4	GO:0005891
GeneOntologyCellularComponent	AP-type membrane coat adaptor complex	AP5S1 AP3B1 AP5Z1 AP3B2	4.39e-04	48	155	4	GO:0030119
GeneOntologyCellularComponent	Z disc	CACNA1C OBSCN RYR2 RYR3 SCN1A ASB2	9.29e-04	151	155	6	GO:0030018
GeneOntologyCellularComponent	I band	CACNA1C OBSCN RYR2 RYR3 SCN1A ASB2	1.51e-03	166	155	6	GO:0031674
GeneOntologyCellularComponent	transmembrane transporter complex	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 NALCN SCN1A SCN2A SCN3A CACNA1H GABRR3	1.84e-03	523	155	11	GO:1902495
Domain	Channel_four-helix_dom	CACNA1C CACNA1F NALCN SCN1A SCN2A SCN3A CACNA1H	4.05e-07	57	153	7	IPR027359
Domain	-	CACNA1C CACNA1F NALCN SCN1A SCN2A SCN3A CACNA1H	4.05e-07	57	153	7	1.20.120.350
Domain	Ion_trans_dom	CACNA1C CACNA1F RYR2 RYR3 NALCN SCN1A SCN2A SCN3A CACNA1H	4.09e-07	114	153	9	IPR005821
Domain	Ion_trans	CACNA1C CACNA1F RYR2 RYR3 NALCN SCN1A SCN2A SCN3A CACNA1H	4.09e-07	114	153	9	PF00520
Domain	Na_trans_cytopl	SCN1A SCN2A SCN3A	1.06e-05	6	153	3	PF11933
Domain	Na_trans_cytopl	SCN1A SCN2A SCN3A	1.06e-05	6	153	3	IPR024583
Domain	Na_channel_asu	SCN1A SCN2A SCN3A	6.20e-05	10	153	3	IPR001696
Domain	Na_trans_assoc	SCN1A SCN2A SCN3A	6.20e-05	10	153	3	IPR010526
Domain	Na_trans_assoc	SCN1A SCN2A SCN3A	6.20e-05	10	153	3	PF06512
Domain	VDCCAlpha1	CACNA1C CACNA1F CACNA1H	6.20e-05	10	153	3	IPR002077
Domain	AP3_beta	AP3B1 AP3B2	6.67e-05	2	153	2	IPR026740
Domain	Cyt_P450_E_grp-I_CYP1	CYP1A1 CYP1A2	6.67e-05	2	153	2	IPR008066
Domain	AP3B_C	AP3B1 AP3B2	6.67e-05	2	153	2	IPR029390
Domain	AP3B1_C	AP3B1 AP3B2	6.67e-05	2	153	2	PF14796
Domain	TATA-bd_TIP120	CAND1 CAND2	6.67e-05	2	153	2	IPR013932
Domain	TIP120	CAND1 CAND2	6.67e-05	2	153	2	PF08623
Domain	AP3B1_C	AP3B1 AP3B2	6.67e-05	2	153	2	SM01355
Domain	Cadherin_2	PCDHGA4 PCDHB10 PCDHB7 PCDH12 PCDHB16	1.92e-04	65	153	5	PF08266
Domain	Cadherin_N	PCDHGA4 PCDHB10 PCDHB7 PCDH12 PCDHB16	1.92e-04	65	153	5	IPR013164
Domain	CAC1F_C	CACNA1C CACNA1F	1.99e-04	3	153	2	IPR031688
Domain	Ryanodine_rcpt	RYR2 RYR3	1.99e-04	3	153	2	IPR003032
Domain	DUF3523	ATAD3C ATAD3A	1.99e-04	3	153	2	IPR021911
Domain	Ryanrecept_TM4-6	RYR2 RYR3	1.99e-04	3	153	2	IPR009460
Domain	RyR	RYR2 RYR3	1.99e-04	3	153	2	PF02026
Domain	DUF3523	ATAD3C ATAD3A	1.99e-04	3	153	2	PF12037
Domain	CAC1F_C	CACNA1C CACNA1F	1.99e-04	3	153	2	PF16885
Domain	RR_TM4-6	RYR2 RYR3	1.99e-04	3	153	2	PF06459
Domain	Ryan_recept	RYR2 RYR3	1.99e-04	3	153	2	IPR013333
Domain	Cadherin_CS	PCDHGA4 PCDHB10 PCDHB7 PCDH12 PCDHB16 CELSR3	2.77e-04	109	153	6	IPR020894
Domain	CADHERIN_1	PCDHGA4 PCDHB10 PCDHB7 PCDH12 PCDHB16 CELSR3	3.37e-04	113	153	6	PS00232
Domain	Cadherin	PCDHGA4 PCDHB10 PCDHB7 PCDH12 PCDHB16 CELSR3	3.37e-04	113	153	6	PF00028
Domain	CADHERIN_2	PCDHGA4 PCDHB10 PCDHB7 PCDH12 PCDHB16 CELSR3	3.53e-04	114	153	6	PS50268
Domain	-	PCDHGA4 PCDHB10 PCDHB7 PCDH12 PCDHB16 CELSR3	3.53e-04	114	153	6	2.60.40.60
Domain	CA	PCDHGA4 PCDHB10 PCDHB7 PCDH12 PCDHB16 CELSR3	3.70e-04	115	153	6	SM00112
Domain	Cadherin_C	PCDHGA4 PCDHB10 PCDHB7 PCDHB16	3.80e-04	42	153	4	IPR032455
Domain	Cadherin_C_2	PCDHGA4 PCDHB10 PCDHB7 PCDHB16	3.80e-04	42	153	4	PF16492
Domain	Cadherin-like	PCDHGA4 PCDHB10 PCDHB7 PCDH12 PCDHB16 CELSR3	3.87e-04	116	153	6	IPR015919
Domain	ARM-like	CAND1 CAND2 TTI2 AP3B1 AP5Z1 ANKAR AP3B2 HTT PPP6R3	3.93e-04	270	153	9	IPR011989
Domain	VDCC_L_a1su	CACNA1C CACNA1F	3.96e-04	4	153	2	IPR005446
Domain	Cadherin	PCDHGA4 PCDHB10 PCDHB7 PCDH12 PCDHB16 CELSR3	4.25e-04	118	153	6	IPR002126
Domain	ARM-type_fold	CAND1 CAND2 TTI2 AP3B1 RYR3 FOCAD ANKAR AP3B2 HTT PPP6R3	4.93e-04	339	153	10	IPR016024
Domain	AP_beta	AP3B1 AP3B2	6.56e-04	5	153	2	IPR026739
Domain	RIH_assoc-dom	RYR2 RYR3	9.79e-04	6	153	2	IPR013662
Domain	-	EPPK1 MACF1	9.79e-04	6	153	2	3.90.1290.10
Domain	Frag1	PGAP2 TMEM150C	9.79e-04	6	153	2	PF10277
Domain	Frag1/DRAM/Sfk1	PGAP2 TMEM150C	9.79e-04	6	153	2	IPR019402
Domain	Ins145_P3_rec	RYR2 RYR3	9.79e-04	6	153	2	PF08709
Domain	RIH_assoc	RYR2 RYR3	9.79e-04	6	153	2	PF08454
Domain	RIH_dom	RYR2 RYR3	9.79e-04	6	153	2	IPR000699
Domain	Ins145_P3_rcpt	RYR2 RYR3	9.79e-04	6	153	2	IPR014821
Domain	Ryanodine_recept-rel	RYR2 RYR3	9.79e-04	6	153	2	IPR015925
Domain	-	RYR2 RYR3	9.79e-04	6	153	2	1.25.10.30
Domain	RYDR_ITPR	RYR2 RYR3	9.79e-04	6	153	2	PF01365
Domain	Plectin	EPPK1 MACF1	1.36e-03	7	153	2	PF00681
Domain	CbamoylP_synth_lsu-like_ATP-bd	CPS1 PC	1.36e-03	7	153	2	IPR005479
Domain	BC-like_N	CPS1 PC	1.36e-03	7	153	2	IPR005481
Domain	Ca_chan_IQ	CACNA1C CACNA1F	1.36e-03	7	153	2	SM01062
Domain	Ca_chan_IQ	CACNA1C CACNA1F	1.36e-03	7	153	2	PF08763
Domain	Plectin_repeat	EPPK1 MACF1	1.36e-03	7	153	2	IPR001101
Domain	VDCC_a1su_IQ	CACNA1C CACNA1F	1.36e-03	7	153	2	IPR014873
Domain	CPSase_L_D2	CPS1 PC	1.36e-03	7	153	2	PF02786
Domain	GPHH	CACNA1C CACNA1F	1.36e-03	7	153	2	PF16905
Domain	GPHH_dom	CACNA1C CACNA1F	1.36e-03	7	153	2	IPR031649
Domain	Biotin_carb_N	CPS1 PC	1.36e-03	7	153	2	PF00289
Domain	PLEC	EPPK1 MACF1	1.36e-03	7	153	2	SM00250
Domain	Leu-rich_rpt	LRRC75B LRRC10B LRRC40 NLRP2 LINGO4 LRRC14 LGR6 FLRT1	1.79e-03	271	153	8	IPR001611
Domain	VPS9	RIN1 RINL	1.81e-03	8	153	2	SM00167
Domain	JMJC	KDM5B JMJD4 RIOX1	2.25e-03	32	153	3	PS51184
Domain	JmjC_dom	KDM5B JMJD4 RIOX1	2.25e-03	32	153	3	IPR003347
Domain	-	CAND1 CAND2 AP3B1 AP5Z1 ANKAR AP3B2 HTT	2.39e-03	222	153	7	1.25.10.10
Domain	JmjC	KDM5B JMJD4 RIOX1	2.46e-03	33	153	3	SM00558
Domain	EF-hand-dom_pair	CACNA1C CACNA1F CABP5 RYR2 RYR3 SCN1A SCN3A MACF1	2.56e-03	287	153	8	IPR011992
Domain	MIR	RYR2 RYR3	2.87e-03	10	153	2	PF02815
Domain	MIR_motif	RYR2 RYR3	2.87e-03	10	153	2	IPR016093
Domain	VPS9	RIN1 RINL	2.87e-03	10	153	2	PS51205
Domain	MIR	RYR2 RYR3	2.87e-03	10	153	2	PS50919
Domain	MIR	RYR2 RYR3	2.87e-03	10	153	2	SM00472
Domain	VPS9	RIN1 RINL	2.87e-03	10	153	2	PF02204
Domain	VPS9	RIN1 RINL	2.87e-03	10	153	2	IPR003123
Domain	-	TENM4 LRP1 LRP5	3.97e-03	39	153	3	2.120.10.30
Domain	IQ	OBSCN SCN1A SCN2A SCN3A	4.42e-03	81	153	4	SM00015
Domain	-	DPYD HAO1 PC	4.90e-03	42	153	3	3.20.20.70
Domain	-	CPS1 PC	4.90e-03	13	153	2	3.40.50.20
Domain	-	LRRC75B LRRC10B LRRC40 NLRP2 LINGO4 LRRC14 LGR6 FLRT1	5.03e-03	321	153	8	3.80.10.10
Domain	Aldolase_TIM	DPYD HAO1 PC	5.58e-03	44	153	3	IPR013785
Domain	ATP_GRASP	CPS1 PC	5.69e-03	14	153	2	PS50975
Domain	ATP-grasp	CPS1 PC	5.69e-03	14	153	2	IPR011761
Domain	PreATP-grasp_dom	CPS1 PC	5.69e-03	14	153	2	IPR016185
Domain	Ldl_recept_b	LRP1 LRP5	5.69e-03	14	153	2	PF00058
Domain	LDLRB	LRP1 LRP5	5.69e-03	14	153	2	PS51120
Domain	SPRY	RYR2 RYR3 TRIM10 RFPL2	5.69e-03	87	153	4	SM00449
Domain	L_dom-like	LRRC75B LRRC10B LRRC40 NLRP2 LINGO4 LRRC14 LGR6 FLRT1	5.71e-03	328	153	8	IPR032675
Domain	Ldl_recept_a	TMPRSS9 LRP1 LRP5	5.95e-03	45	153	3	PF00057
Domain	6-blade_b-propeller_TolB-like	TENM4 LRP1 LRP5	6.32e-03	46	153	3	IPR011042
Domain	-	TMPRSS9 LRP1 LRP5	6.32e-03	46	153	3	4.10.400.10
Domain	IQ_motif_EF-hand-BS	OBSCN SCN1A SCN2A SCN3A	6.41e-03	90	153	4	IPR000048
Domain	Clathrin/coatomer_adapt-like_N	AP3B1 AP3B2	6.53e-03	15	153	2	IPR002553
Domain	LY	LRP1 LRP5	6.53e-03	15	153	2	SM00135
Domain	Adaptin_N	AP3B1 AP3B2	6.53e-03	15	153	2	PF01602
Domain	-	CPS1 PC	6.53e-03	15	153	2	3.30.1490.20
Pathway	REACTOME_MUSCLE_CONTRACTION	CACNA1C VIM CACNA2D2 RYR2 RYR3 GUCY1A2 SCN1A SCN2A SCN3A CACNA1H	3.80e-06	203	109	10	M5485
Pathway	REACTOME_PHASE_0_RAPID_DEPOLARISATION	CACNA1C CACNA2D2 SCN1A SCN2A SCN3A	4.30e-06	32	109	5	M27455
Pathway	WP_ALZHEIMERS_DISEASE	CACNA1C CACNA1F RYR3 LRP1 TNFRSF1A EIF2AK3	2.25e-05	74	109	6	MM15962
Pathway	WP_RETT_SYNDROME	KDM5B STXBP1 SCN1A SCN2A HTT	3.31e-05	48	109	5	M39759
Pathway	KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL	CACNA1C CACNA1F CACNA2D2 CACNA1H	3.77e-05	25	109	4	M47948
Pathway	WP_DRAVET_SYNDROME	STXBP1 SCN1A SCN2A SCN3A	6.00e-05	28	109	4	M45519
Pathway	REACTOME_CARDIAC_CONDUCTION	CACNA1C CACNA2D2 RYR2 RYR3 SCN1A SCN2A SCN3A	6.59e-05	130	109	7	M27454
Pathway	KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY	CACNA1C RYR2 RYR3	7.09e-05	11	109	3	M47958
Pathway	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	CACNA1C CACNA1F CACNA2D2 ITGA10 RYR2	2.66e-04	74	109	5	M16376
Pathway	WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY	CACNA1C CACNA1F CACNA2D2 ITGA10 RYR2	2.66e-04	74	109	5	M39462
Pathway	WP_15Q25_COPY_NUMBER_VARIATION	RYR2 AP3B2 ALPK3 HTT	4.30e-04	46	109	4	M48105
Pathway	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	CACNA1C CACNA1F CACNA2D2 ITGA10 RYR2	4.53e-04	83	109	5	M8728
Pathway	KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING	CACNA1C CACNA2D2 RYR2	5.40e-04	21	109	3	M47950
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SHROOM3 RTL6 EPPK1 BICRA ANKRD9 OBSCN TWNK GRID1 ICE1 FOCAD HEYL ARAP3 PNPLA6 CELSR3 TRIB3 BTBD7 CPSF1 LRP5 CACNA1H LRRC14 ZNF324B PC ALKBH6 HTT	2.28e-10	1105	158	24	35748872
Pubmed	SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.	SCN1A SCN2A SCN3A	9.20e-08	3	158	3	23859570
Pubmed	Synaptic ribbons foster active zone stability and illumination-dependent active zone enrichment of RIM2 and Cav1.4 in photoreceptor synapses.	CACNA1F AP3B1 CTBP2	9.20e-08	3	158	3	32249787
Pubmed	Sodium channels SCN1A, SCN2A and SCN3A in familial autism.	SCN1A SCN2A SCN3A	9.20e-08	3	158	3	12610651
Pubmed	Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression.	SCN1A SCN2A SCN3A	9.20e-08	3	158	3	18784617
Pubmed	Characterization of 5' untranslated regions of the voltage-gated sodium channels SCN1A, SCN2A, and SCN3A and identification of cis-conserved noncoding sequences.	SCN1A SCN2A SCN3A	9.20e-08	3	158	3	17544618
Pubmed	Early expression of sodium channel transcripts and sodium current by cajal-retzius cells in the preplate of the embryonic mouse neocortex.	SCN1A SCN2A SCN3A	9.20e-08	3	158	3	14973256
Pubmed	The layered structure of human mitochondrial DNA nucleoids.	SHMT2 TWNK CPS1 ATAD3A DDX28	3.31e-07	32	158	5	18063578
Pubmed	Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation.	SCN1A SCN2A SCN3A	3.67e-07	4	158	3	17537961
Pubmed	Association of sodium voltage-gated channel genes polymorphisms with epilepsy risk and prognosis in the Saudi population.	SCN1A SCN2A SCN3A	3.67e-07	4	158	3	35801810
Pubmed	Sodium channel expression and transcript variation in the developing brain of human, Rhesus monkey, and mouse.	SCN1A SCN2A SCN3A	3.67e-07	4	158	3	35031483
Pubmed	Abnormal changes in voltage-gated sodium channels subtypes NaV1.1, NaV1.2, NaV1.3, NaV1.6 and CaM/CaMKII pathway in low-grade astrocytoma.	SCN1A SCN2A SCN3A	3.67e-07	4	158	3	29578003
Pubmed	Use of recombinant inbred strains for studying genetic determinants of responses to alcohol.	SCN1A SCN2A SCN3A	3.67e-07	4	158	3	8974318
Pubmed	Three brain sodium channel alpha-subunit genes are clustered on the proximal segment of mouse chromosome 2.	SCN1A SCN2A SCN3A	9.14e-07	5	158	3	1679748
Pubmed	A new sodium channel alpha-subunit gene (Scn9a) from Schwann cells maps to the Scn1a, Scn2a, Scn3a cluster of mouse chromosome 2.	SCN1A SCN2A SCN3A	9.14e-07	5	158	3	8812438
Pubmed	Case-control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy.	SCN1A SCN2A SCN3A	9.14e-07	5	158	3	24337656
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGA4 PCDHB10 PCDHB7 PCDH12 PCDHB16 CELSR3	9.75e-07	72	158	6	10380929
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGA4 PCDHB10 PCDHB7 PCDH12 PCDHB16 CELSR3	1.82e-06	80	158	6	10716726
Pubmed	HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization.	RYR2 RYR3 EIF2AK3	1.82e-06	6	158	3	19009018
Pubmed	A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain.	SCN1A SCN2A SCN3A	1.82e-06	6	158	3	23652591
Pubmed	ER stress disrupts Ca2+-signaling complexes and Ca2+ regulation in secretory and muscle cells from PERK-knockout mice.	CACNA1C RYR2 EIF2AK3	1.82e-06	6	158	3	16352659
Pubmed	Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.	STXBP1 SCN1A SCN2A	3.18e-06	7	158	3	25818041
Pubmed	Enhanced expression of L-type Cav1.3 calcium channels in murine embryonic hearts from Cav1.2-deficient mice.	CACNA1C CACNA1F CACNA1H	3.18e-06	7	158	3	12900400
Pubmed	Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development.	CACNA1C CACNA1F CACNA2D2 RYR2 SCN1A SCN3A CACNA1H	3.61e-06	139	158	7	16985003
Pubmed	ATAD3A oligomerization causes neurodegeneration by coupling mitochondrial fragmentation and bioenergetics defects.	ATAD3C ATAD3A HTT	5.07e-06	8	158	3	30914652
Pubmed	Sequential docking, molecular differentiation, and positioning of T-Tubule/SR junctions in developing mouse skeletal muscle.	CACNA1C RYR2 RYR3	5.07e-06	8	158	3	11784029
Pubmed	CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathway.	VIM SHROOM3 ATAD3A MIB1 PC	6.28e-06	57	158	5	36849460
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	VIM OBSCN GRID1 CARD8 RIN1 STXBP1 LRP1 LRP5	6.58e-06	214	158	8	22199357
Pubmed	International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels.	SCN1A SCN2A SCN3A	7.57e-06	9	158	3	16382098
Pubmed	International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels.	CACNA1C CACNA1F CACNA1H	7.57e-06	9	158	3	16382099
Pubmed	Expression pattern of neuronal and skeletal muscle voltage-gated Na+ channels in the developing mouse heart.	SCN1A SCN2A SCN3A	7.57e-06	9	158	3	15746173
Pubmed	Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment.	CYP1A2 SCN1A SCN2A	1.08e-05	10	158	3	20602612
Pubmed	NCAM induces CaMKIIalpha-mediated RPTPalpha phosphorylation to enhance its catalytic activity and neurite outgrowth.	CACNA1C CACNA1F CACNA1H	1.48e-05	11	158	3	18809727
Pubmed	New molecular components supporting ryanodine receptor-mediated Ca(2+) release: roles of junctophilin and TRIC channel in embryonic cardiomyocytes.	CACNA1C RYR2 RYR3	1.96e-05	12	158	3	19095005
Pubmed	Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice.	SCN1A SCN2A SCN3A	1.96e-05	12	158	3	30175250
Pubmed	Quantitative trait loci mapping of genes that influence the sensitivity and tolerance to ethanol-induced hypothermia in BXD recombinant inbred mice.	SCN1A SCN2A SCN3A	1.96e-05	12	158	3	8169823
Pubmed	Array-CGH detection of a de novo 2.8 Mb deletion in 2q24.2-->q24.3 in a girl with autistic features and developmental delay.	SCN2A SCN3A	2.05e-05	2	158	2	20346423
Pubmed	Methylation differences in the murine P1450 and P3450 genes in wild-type and mutant hepatoma cell culture.	CYP1A1 CYP1A2	2.05e-05	2	158	2	2425809
Pubmed	PERK-ATAD3A interaction provides a subcellular safe haven for protein synthesis during ER stress.	ATAD3A EIF2AK3	2.05e-05	2	158	2	39116259
Pubmed	Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice.	SCN1A SCN2A	2.05e-05	2	158	2	10827969
Pubmed	Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6.	CYP1A1 CYP1A2	2.05e-05	2	158	2	3000715
Pubmed	"ATAD3C regulates ATAD3A assembly and function in the mitochondrial membrane".	ATAD3C ATAD3A	2.05e-05	2	158	2	38092275
Pubmed	Characterization of human CYP1A1/1A2 induction by DNA microarray and alpha-naphthoflavone.	CYP1A1 CYP1A2	2.05e-05	2	158	2	12147246
Pubmed	Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS.	CYP1A1 CYP1A2	2.05e-05	2	158	2	17852022
Pubmed	Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population.	SCN1A SCN2A	2.05e-05	2	158	2	19694741
Pubmed	Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus.	SCN2A SCN3A	2.05e-05	2	158	2	11245985
Pubmed	Cyp1a2 protects against reactive oxygen production in mouse liver microsomes.	CYP1A1 CYP1A2	2.05e-05	2	158	2	14980704
Pubmed	Differential expression of two sodium channel subtypes in human brain.	SCN1A SCN2A	2.05e-05	2	158	2	1317301
Pubmed	Characterization of Ca2+-binding protein 5 knockout mouse retina.	CACNA1C CABP5	2.05e-05	2	158	2	18586882
Pubmed	Immunocytochemical study of cytochrome P450 (1A1/1A2) induction in murine ocular tissues.	CYP1A1 CYP1A2	2.05e-05	2	158	2	7781742
Pubmed	Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation.	CYP1A1 CYP1A2	2.05e-05	2	158	2	11207026
Pubmed	Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy.	SCN2A SCN3A	2.05e-05	2	158	2	23016767
Pubmed	Tissue-specific expression of the mouse dioxin-inducible P(1)450 and P(3)450 genes: differential transcriptional activation and mRNA stability in liver and extrahepatic tissues.	CYP1A1 CYP1A2	2.05e-05	2	158	2	3785172
Pubmed	Assignment of dioxin-inducible cytochrome P-450 gene family to Chinese hamster chromosome 4.	CYP1A1 CYP1A2	2.05e-05	2	158	2	3860967
Pubmed	Whole gene duplication of SCN2A and SCN3A is associated with neonatal seizures and a normal intellectual development.	SCN2A SCN3A	2.05e-05	2	158	2	27153334
Pubmed	Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype.	CYP1A1 CYP1A2	2.05e-05	2	158	2	16609368
Pubmed	Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A.	SCN1A SCN3A	2.05e-05	2	158	2	24990319
Pubmed	Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria.	CYP1A1 CYP1A2	2.05e-05	2	158	2	15094312
Pubmed	Clinical exome sequencing identifies two novel mutations of the SCN1A and SCN2A genes in Moroccan patients with epilepsy: a case series.	SCN1A SCN2A	2.05e-05	2	158	2	31439038
Pubmed	Tissue-specific alternative splicing of mouse brain type ryanodine receptor/calcium release channel mRNA.	RYR2 RYR3	2.05e-05	2	158	2	8898078
Pubmed	CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines.	CYP1A1 CYP1A2	2.05e-05	2	158	2	19285097
Pubmed	Genetic interactions found between calcium channel genes modulate amyloid load measured by positron emission tomography.	CACNA1C RYR3	2.05e-05	2	158	2	24026422
Pubmed	[Association of polymorph variants of CYP1A2 and CYP1A1 genes with reproductive and thyroid diseases in female workers of petrochemical industry].	CYP1A1 CYP1A2	2.05e-05	2	158	2	22855999
Pubmed	Differential regulation of expression of hepatic and pulmonary cytochrome P4501A enzymes by 3-methylcholanthrene in mice lacking the CYP1A2 gene.	CYP1A1 CYP1A2	2.05e-05	2	158	2	12438513
Pubmed	CACNA1H downregulation induces skeletal muscle atrophy involving endoplasmic reticulum stress activation and autophagy flux blockade.	CACNA1C CACNA1H	2.05e-05	2	158	2	32332705
Pubmed	The mouse sino-atrial node expresses both the type 2 and type 3 Ca(2+) release channels/ryanodine receptors.	RYR2 RYR3	2.05e-05	2	158	2	14550562
Pubmed	HNK-1 epitope-carrying tenascin-C spliced variant regulates the proliferation of mouse embryonic neural stem cells.	TNC B3GAT1	2.05e-05	2	158	2	20855890
Pubmed	Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A.	SCN1A SCN2A	2.05e-05	2	158	2	15249644
Pubmed	Mapping of a FEB3 homologous febrile seizure locus on mouse chromosome 2 containing candidate genes Scn1a and Scn3a.	SCN1A SCN3A	2.05e-05	2	158	2	27690330
Pubmed	Systematic screening identifies a 2-gene signature as a high-potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma.	ITGA10 PPP2R2B	2.05e-05	2	158	2	31742892
Pubmed	Induction of cytochromes P450 1A1 and 1A2 by tanshinones in human HepG2 hepatoma cell line.	CYP1A1 CYP1A2	2.05e-05	2	158	2	21262253
Pubmed	Epidermal Growth Factor Receptor Kinase Inhibitors Synergize with TCDD to Induce CYP1A1/1A2 in Human Breast Epithelial MCF10A Cells.	CYP1A1 CYP1A2	2.05e-05	2	158	2	26953171
Pubmed	Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition.	CYP1A1 CYP1A2	2.05e-05	2	158	2	18493746
Pubmed	Polycyclic Aromatic Hydrocarbon-induced Pulmonary Carcinogenesis in Cytochrome P450 (CYP)1A1- and 1A2-Null Mice: Roles of CYP1A1 and CYP1A2.	CYP1A1 CYP1A2	2.05e-05	2	158	2	32726451
Pubmed	A shuffled CYP1A library shows both structural integrity and functional diversity.	CYP1A1 CYP1A2	2.05e-05	2	158	2	17823232
Pubmed	Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome.	SCN1A SCN3A	2.05e-05	2	158	2	23965409
Pubmed	Comparison of the flanking regions and introns of the mouse 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P1-450 and P3-450 genes.	CYP1A1 CYP1A2	2.05e-05	2	158	2	3988744
Pubmed	CYP1A1 and CYP1A2 expression levels are differentially regulated in three-dimensional spheroids of liver cancer cells compared to two-dimensional monolayer cultures.	CYP1A1 CYP1A2	2.05e-05	2	158	2	26643992
Pubmed	Preferred binding orientations of phenacetin in CYP1A1 and CYP1A2 are associated with isoform-selective metabolism.	CYP1A1 CYP1A2	2.05e-05	2	158	2	22949628
Pubmed	Role of defective calcium regulation in cardiorespiratory dysfunction in Huntington's disease.	RYR2 HTT	2.05e-05	2	158	2	32897880
Pubmed	SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.	SCN1A SCN2A	2.05e-05	2	158	2	30693367
Pubmed	Increased basal expression of hepatic Cyp1a1 and Cyp1a2 genes in inbred mice selected for susceptibility to acetaminophen-induced hepatotoxicity.	CYP1A1 CYP1A2	2.05e-05	2	158	2	9295056
Pubmed	Disruption of cytochrome P4501A2 in mice leads to increased susceptibility to hyperoxic lung injury.	CYP1A1 CYP1A2	2.05e-05	2	158	2	25680282
Pubmed	Association between SCN1A and SCN2A mutations and clinical/EEG features in Chinese patients from epilepsy or severe seizures.	SCN1A SCN2A	2.05e-05	2	158	2	29649454
Pubmed	Sex-specific differences in hyperoxic lung injury in mice: role of cytochrome P450 (CYP)1A.	CYP1A1 CYP1A2	2.05e-05	2	158	2	25703676
Pubmed	Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease.	RYR2 RYR3	2.05e-05	2	158	2	21531043
Pubmed	Developmental and tissue-specific differential regulation of the mouse dioxin-inducible P1-450 and P3-450 genes.	CYP1A1 CYP1A2	2.05e-05	2	158	2	4054433
Pubmed	Modulation of calcium signalling by dominant negative splice variant of ryanodine receptor subtype 3 in native smooth muscle cells.	RYR2 RYR3	2.05e-05	2	158	2	16678258
Pubmed	Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice.	CYP1A1 CYP1A2	2.05e-05	2	158	2	31147315
Pubmed	Aryl hydrocarbon (Ah) receptor-independent induction of Cyp1a2 gene expression by acenaphthylene and related compounds in B6C3F1 mice.	CYP1A1 CYP1A2	2.05e-05	2	158	2	8001243
Pubmed	Metabolism of 4-n-nonylphenol by non-modified and CYP1A1- and CYP1A2-transgenic cell cultures of tobacco.	CYP1A1 CYP1A2	2.05e-05	2	158	2	16402549
Pubmed	The effect of CYP1A1 and CYP1A2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis.	CYP1A1 CYP1A2	2.05e-05	2	158	2	24443269
Pubmed	Preferential inducibility of CYP1A1 and CYP1A2 by TCDD: differential regulation in primary human hepatocytes versus transformed human cells.	CYP1A1 CYP1A2	2.05e-05	2	158	2	16426572
Pubmed	Chronic hypoxia selectively enhances L- and T-type voltage-dependent Ca2+ channel activity in pulmonary artery by upregulating Cav1.2 and Cav3.2.	CACNA1C CACNA1H	2.05e-05	2	158	2	23686856
Pubmed	The influence of CYP1A1 and CYP1A2 polymorphisms on stroke risk in the Chinese population.	CYP1A1 CYP1A2	2.05e-05	2	158	2	33046100
Pubmed	Ca2+ influx through T- and L-type Ca2+ channels have different effects on myocyte contractility and induce unique cardiac phenotypes.	CACNA1C CACNA1H	2.05e-05	2	158	2	18832749
Pubmed	Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children.	SCN1A SCN2A	2.05e-05	2	158	2	33096315
Pubmed	CYP1A1/2 haplotypes and lung cancer and assessment of confounding by population stratification.	CYP1A1 CYP1A2	2.05e-05	2	158	2	19276377
Pubmed	Distinct genetic patterns of shared and unique genes across four neurodevelopmental disorders.	STXBP1 SCN2A	2.05e-05	2	158	2	32929885
Pubmed	Skeletal and cardiac ryanodine receptors bind to the Ca(2+)-sensor region of dihydropyridine receptor alpha(1C) subunit.	CACNA1C RYR2	2.05e-05	2	158	2	11576544
Cytoband	5q31	PCDHGA4 PCDHB10 PCDHB7 PCDH12 PCDHB16	5.13e-05	115	158	5	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	CABP5 BICRA FPR3 KLK12 SIGLEC5 BCL3 NLRP2 CARD8 GIPR FCGBP ZNF324 ZNF324B RINL ALKBH6	7.04e-05	1192	158	14	chr19q13
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHGA4 PCDHB10 PCDHB7 PCDH12 PCDHB16 ARAP3	6.12e-04	298	158	6	chr5q31
GeneFamily	Calcium voltage-gated channel subunits	CACNA1C CACNA1F CACNA2D2 CACNA1H	1.75e-05	26	110	4	253
GeneFamily	Sodium voltage-gated channel alpha subunits	SCN1A SCN2A SCN3A	1.79e-05	9	110	3	1203
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR2 RYR3	1.10e-04	3	110	2	287
GeneFamily	Cytochrome P450 family 1	CYP1A1 CYP1A2	2.18e-04	4	110	2	1000
GeneFamily	Clustered protocadherins	PCDHGA4 PCDHB10 PCDHB7 PCDHB16	6.22e-04	64	110	4	20
GeneFamily	Ankyrin repeat domain containing	ANKRD9 BCL3 ASB12 ARAP3 ANKAR MIB1 ASB2	6.98e-04	242	110	7	403
GeneFamily	EF-hand domain containing\|Plakins	EPPK1 MACF1	1.00e-03	8	110	2	939
GeneFamily	VPS9 domain containing	RIN1 RINL	1.60e-03	10	110	2	928
GeneFamily	Low density lipoprotein receptors	LRP1 LRP5	2.74e-03	13	110	2	634
GeneFamily	Fibronectin type III domain containing	COL7A1 TNC OBSCN IGSF9 FLRT1	2.96e-03	160	110	5	555
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	CACNA1C EPPK1 TNC HEYL GUCY1A2 SCN3A CACNA1H LGR6	1.15e-07	161	158	8	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	CACNA1C EPPK1 LRRC10B GRID1 HEYL SCN3A CACNA1H LGR6	2.60e-07	179	158	8	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F OBSCN GRID1 CPS1 RYR2 RYR3 TENM4 SCN2A	3.20e-07	184	158	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F OBSCN GRID1 CPS1 RYR2 RYR3 TENM4 SCN2A	3.20e-07	184	158	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F OBSCN GRID1 CPS1 RYR2 RYR3 TENM4 SCN2A	3.20e-07	184	158	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C POPDC2 RYR2 HEYL GUCY1A2 CACNA1H LGR6 ASB2	4.09e-07	190	158	8	73d94fbae92029745989a8712eed8b99fd84c193
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C LRRC10B RYR2 HEYL GUCY1A2 SCN3A CACNA1H ASB2	4.26e-07	191	158	8	8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC GRID1 RYR2 TENM4 NALCN LRP1 LGR6	4.26e-07	191	158	8	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D2 OBSCN POPDC2 RYR2 ALPK3 CACNA1H ASB2 INPP5J	4.26e-07	191	158	8	c172c9e17b893b290e4aa8af5e5e4cd3e4818372
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D2 OBSCN POPDC2 RYR2 ALPK3 CACNA1H ASB2 INPP5J	4.26e-07	191	158	8	715f5b449b8e075959c05a5b38389df319663164
ToppCell	droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FAM174B POPDC2 RYR2 ALPK3 CACNA1H LGR6 ASB2	4.43e-07	192	158	8	0bf99e029a06151092db1e8a0dcb45f4e688e771
ToppCell	droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FAM174B POPDC2 RYR2 ALPK3 CACNA1H LGR6 ASB2	4.43e-07	192	158	8	d766221acfce30cbf2c60b3ae40f6744968b952c
ToppCell	nucseq-Mesenchymal-Myocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C COL7A1 OBSCN RYR2 HEYL TENM4 GUCY1A2 CACNA1H	4.79e-07	194	158	8	2d66091097e106c7bee22e5281f50724700bdf8d
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C VIM GRID1 RYR2 HEYL SCN3A ALPK3 CACNA1H	5.59e-07	198	158	8	7dd874b09c81cc512ccc1e9b65f290a5f94d736e
ToppCell	RV-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	CACNA1C EPPK1 TNC GUCY1A2 SCN3A CACNA1H LGR6	1.71e-06	160	158	7	29c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C HEYL GUCY1A2 B3GAT1 CACNA1H LGR6 ASB2	1.94e-06	163	158	7	51dee6c21cbeca4e17d1cc386e203f0c403089e8
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	CACNA1C OBSCN GRID1 RYR2 HEYL GUCY1A2 CACNA1H	2.67e-06	171	158	7	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC10B GRID1 RYR2 HEYL SCN3A CACNA1H LGR6	3.11e-06	175	158	7	316f2ea930437bf1243b1c0f45e6bd864112c6f2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC10B GRID1 RYR2 HEYL SCN3A CACNA1H LGR6	3.11e-06	175	158	7	a9f08e1e4c2997dcdd3e5d92daac480da19100b8
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C OBSCN GRID1 RYR2 HEYL GUCY1A2 CACNA1H	3.48e-06	178	158	7	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VIM LRRC10B GRID1 CELSR3 SCN3A AP3B2 CACNA1H	3.48e-06	178	158	7	30ca37f70d267cc9b40ca3e211f16d30360c3e6b
ToppCell	Adult-Mesenchymal-pericyte_cell-D122\|Adult / Lineage, Cell type, age group and donor	CACNA1C COL7A1 OBSCN RYR2 HEYL GUCY1A2 CACNA1H	4.17e-06	183	158	7	fc31a43a637423cb3bb9aa184a3a889a0b9aaea6
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C OBSCN POPDC2 RYR2 NALCN ALPK3 ASB2	4.32e-06	184	158	7	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C POPDC2 RYR2 HEYL GUCY1A2 LGR6 ASB2	4.64e-06	186	158	7	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C OBSCN GRID1 RYR2 HEYL GUCY1A2 CACNA1H	4.81e-06	187	158	7	86250acf088ec0c4800a0dfa031b0d4f7e52c342
ToppCell	Adult-Mesenchymal-pericyte_cell\|Adult / Lineage, Cell type, age group and donor	CACNA1C COL7A1 OBSCN RYR2 HEYL GUCY1A2 CACNA1H	4.81e-06	187	158	7	62759efb660179402fb574ce5701c89a2e17bcfe
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C OBSCN GRID1 RYR2 HEYL GUCY1A2 CACNA1H	4.81e-06	187	158	7	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	CACNA1C SHROOM3 TNC RYR2 RYR3 SCN3A MACF1	4.98e-06	188	158	7	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C OBSCN GRID1 RYR2 HEYL GUCY1A2 CACNA1H	4.98e-06	188	158	7	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LRRC10B RYR2 HEYL GUCY1A2 ZNF324 CACNA1H ASB2	4.98e-06	188	158	7	a5e7a363fbd5ae4d9312cf6f9941413d6a5c0b4d
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	CACNA1C OBSCN GRID1 RYR2 HEYL GUCY1A2 CACNA1H	5.16e-06	189	158	7	d7ed96add29f219183c802895fbff519b627f635
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC RYR2 TENM4 NALCN LRP1 LGR6	5.16e-06	189	158	7	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C OBSCN GRID1 RYR2 HEYL GUCY1A2 CACNA1H	5.34e-06	190	158	7	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C OBSCN GRID1 RYR2 HEYL GUCY1A2 CACNA1H	5.34e-06	190	158	7	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN POPDC2 RYR2 RYR3 ALPK3 ASB2 INPP5J	5.53e-06	191	158	7	97fb4232417a39801e87725755fd16a57c250209
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C LRRC10B RYR2 GUCY1A2 SCN3A CACNA1H ASB2	5.53e-06	191	158	7	60bc1f3efa7bbad5cb7944fe5e049ea79cd1745a
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C TNC RYR2 TENM4 NALCN LGR6 ASB2	5.53e-06	191	158	7	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN POPDC2 RYR2 RYR3 ALPK3 ASB2 INPP5J	5.53e-06	191	158	7	64070a309d7e3f6001272409ab9ce206d0e7d73f
ToppCell	droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C CACNA2D2 OBSCN POPDC2 RYR2 ALPK3 ASB2	5.72e-06	192	158	7	f6a4e348406a852ace9fb21db8fbdff539217645
ToppCell	droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C CACNA2D2 OBSCN POPDC2 RYR2 ALPK3 ASB2	5.72e-06	192	158	7	1a0c25106ae08eac912a4edd5fc1a3ee776f69c2
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	CES1P1 CACNA1C COL7A1 TNC RYR2 NALCN MACF1	5.92e-06	193	158	7	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|lung / Disease (COVID-19 only), tissue and cell type	CACNA1C GRID1 RYR2 HEYL GUCY1A2 CACNA1H ASB2	6.12e-06	194	158	7	5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
ToppCell	proximal-Epithelial-Serous-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FAM174B FKBP11 FCGBP NOXO1 BPIFB4 MAST1 GJC3	6.33e-06	195	158	7	06b73abc1f32543f2a51db52dc6424a2a398fe0f
ToppCell	proximal-Epithelial-Serous\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FAM174B FKBP11 FCGBP NOXO1 BPIFB4 MAST1 GJC3	6.33e-06	195	158	7	cb62f04f0e45bfb36eed2e7a3fc54d6d390b2ed1
ToppCell	proximal-3-Epithelial-Serous\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FAM174B FKBP11 FCGBP NOXO1 BPIFB4 MAST1 GJC3	6.33e-06	195	158	7	24a6a566143b04e37ad002e4c55037a0460ac2ef
ToppCell	severe-Lymphocytic-CD8_T_cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	RTL6 CACNA2D2 PPP2R2B MACF1 B3GAT1 LGR6 PDZD4	6.55e-06	196	158	7	d83acd9abd7b296989b8ae09da63799e6877a149
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C GRID1 RYR2 HEYL GUCY1A2 CACNA1H LGR6	6.55e-06	196	158	7	754a3613340932563cd8424d775e18b93c3a1aaa
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C GASK1B RYR3 PPP2R2B NALCN LGR6 ASB2	6.77e-06	197	158	7	f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C OBSCN GRID1 RYR2 HEYL GUCY1A2 CACNA1H	6.77e-06	197	158	7	f66945f9007d59d4208849c7fd727f8519713fbc
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C OBSCN GRID1 RYR2 HEYL GUCY1A2 CACNA1H	6.77e-06	197	158	7	41dd312f46a2b983c8d864adeb6970c0ca4a8048
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C RYR2 PPP2R2B ALPK3 CACNA1H LGR6 ASB2	6.77e-06	197	158	7	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C TNC RYR2 HEYL GUCY1A2 CACNA1H ASB2	6.99e-06	198	158	7	bd42c03e384e64f61b02618cf1a5440033bb04b2
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1C RYR2 FOCAD STXBP1 SCN1A SCN2A SCN3A	6.99e-06	198	158	7	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1C RYR2 FOCAD STXBP1 SCN1A SCN2A SCN3A	6.99e-06	198	158	7	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1C RYR2 FOCAD TENM4 STXBP1 SCN1A SCN2A	6.99e-06	198	158	7	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1C RYR2 FOCAD STXBP1 SCN1A SCN2A SCN3A	6.99e-06	198	158	7	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C RYR2 PPP2R2B ALPK3 CACNA1H LGR6 ASB2	6.99e-06	198	158	7	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	CACNA2D2 GRID1 POPDC2 RYR2 HEYL SCN3A CACNA1H	6.99e-06	198	158	7	0f1feed8a37293ae02465909f99548ab58dc7ce5
ToppCell	Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C OBSCN GRID1 RYR2 HEYL GUCY1A2 CACNA1H	7.23e-06	199	158	7	929f809579368201331d9099d8904b6e3c41797b
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZDHHC21 COL7A1 SHROOM3 CACNA2D2 SCN2A MACF1 INPP5J	7.23e-06	199	158	7	3cd6383c50ce342fe5c175e2e50784d634a90e80
ToppCell	Bronchial-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C OBSCN GRID1 RYR2 HEYL GUCY1A2 CACNA1H	7.23e-06	199	158	7	854628ce91068093c14bd4d45ba38c41469f3549
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26\|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type.	TNC OBSCN ITGA10 RYR2 SCN2A LGR6 PDZD4	7.47e-06	200	158	7	61d7dd0a78942b069c3f5e75044368dc00e6e8e6
ToppCell	Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C OBSCN GRID1 RYR2 HEYL GUCY1A2 CACNA1H	7.47e-06	200	158	7	12326cc6f0af24bacba9493dc79e7c7347db2f41
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GALNT15 CACNA1C VIM TNC ITGA10 TIPARP LRP1	7.47e-06	200	158	7	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C TNC RYR2 HEYL GUCY1A2 CACNA1H ASB2	7.47e-06	200	158	7	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	Bronchial-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C OBSCN GRID1 RYR2 HEYL GUCY1A2 CACNA1H	7.47e-06	200	158	7	362706445edb33b313684efe50b1f44f5f816e67
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	TNC OBSCN ITGA10 RYR2 SCN2A MAST1 PDZD4	7.47e-06	200	158	7	5c7263c862093ad9dbc81d06b16b6f74e8a6b634
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T\|COVID-19_Severe / Disease, condition lineage and cell class	CACNA2D2 PPP2R2B FCGBP MACF1 B3GAT1 LGR6 PDZD4	7.47e-06	200	158	7	f72bc3f6606ae77fe1b0a972e35b3ce0727804d9
ToppCell	Basal_cells-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	COL7A1 EPPK1 TNC TMEM150C IGSF9 LGR6	2.66e-05	164	158	6	85487a303194f5244956ec1ca2d1758d38117f41
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C LRRC10B RYR2 HEYL GUCY1A2 CACNA1H	2.75e-05	165	158	6	8a82e20c9b1156bb4bbc16f7785abb04458d671b
ToppCell	356C-Fibroblasts-Fibroblast-D\|356C / Donor, Lineage, Cell class and subclass (all cells)	COL7A1 EVC2 PCDHB10 PCDHB16 RYR2 GUCY1A2	2.85e-05	166	158	6	7286a37b2827f3747469ffd0d76cbe81116db7ee
ToppCell	356C-Fibroblasts-Fibroblast-D-\|356C / Donor, Lineage, Cell class and subclass (all cells)	COL7A1 EVC2 PCDHB10 PCDHB16 RYR2 GUCY1A2	2.85e-05	166	158	6	7c2eee0a4f45795a956acf936b85bdb35f1b1624
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL7A1 TNC ITGA10 RIN1 PPP2R2B FLRT1	2.94e-05	167	158	6	743df5908c1ceb43b34b240d9f9649f30f4142fa
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SEMA4G SCN1A LINGO4 MAST1 INPP5J PDZD4	2.94e-05	167	158	6	9efb9511a211d0824bb97f82c1a5860c43d2138f
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL7A1 TNC ITGA10 RIN1 PPP2R2B FLRT1	2.94e-05	167	158	6	1adb566f98af0109c8cc6e36033b89651e2c75e7
ToppCell	Cerebellum-Neuronal-Inhibitory\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SEMA4G SCN1A LINGO4 MAST1 INPP5J PDZD4	2.94e-05	167	158	6	904c613aac3f9919a432b110bb1dcc832b5aec0a
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	CACNA1C CAND2 ITGA10 RIN1 TENM4 LGR6	2.94e-05	167	158	6	c4e321bb87512ea839f324c92c0f1afea891483f
ToppCell	Adult-Mesenchymal-pericyte_cell-D175\|Adult / Lineage, Cell type, age group and donor	CACNA1C OBSCN GRID1 RYR2 HEYL GUCY1A2	3.59e-05	173	158	6	fd6653d6be9ca6ac36798590694efe03cb758c67
ToppCell	droplet-Heart-4Chambers-21m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D2 OBSCN FAM174B RYR2 CACNA1H ASB2	3.71e-05	174	158	6	f098778ea74012861ec74b425e45776a31f67679
ToppCell	facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 ITGA10 GUCY1A2 SCN3A FLRT1 ASB2	3.83e-05	175	158	6	d8e385320f554d974538b7cdc4f8e4767f1455f2
ToppCell	COVID-19-Heart-VSMC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C GRID1 HEYL SCN3A CACNA1H LGR6	3.83e-05	175	158	6	1125f0d3a5b2388fa77a820dea0288e824d84a82
ToppCell	facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 ITGA10 GUCY1A2 SCN3A FLRT1 ASB2	3.83e-05	175	158	6	cf15465855602ba135752c18755e3e058dbd42ec
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CELSR3 NALCN SCN2A AP3B2 MAST1 B3GAT1	3.95e-05	176	158	6	116741fef5895ca85057d2d31eca9eba5764ab44
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL7A1 HAUS6 RTL6 POPDC2 RDH16 ASB2	3.95e-05	176	158	6	27e5115fae5f0f63b333bc99fbf6a6d4c9182c46
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CELSR3 NALCN SCN2A AP3B2 MAST1 B3GAT1	3.95e-05	176	158	6	5b707f58d164ee7a6a527dd5d053472ce9a631c1
ToppCell	droplet-Skin-nan-18m-Lymphocytic-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G VIM FAM174B ARAP3 CD163L1 RINL	4.21e-05	178	158	6	12d5c6be6cfbf733e3cb02780606b3725eda7d2b
ToppCell	droplet-Skin-nan-18m-Lymphocytic-T_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G VIM FAM174B ARAP3 CD163L1 RINL	4.21e-05	178	158	6	e0769ad06f92423a3cb6c78a61da3ba5bd9b4eae
ToppCell	droplet-Skin-nan-18m-Lymphocytic\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G VIM FAM174B ARAP3 CD163L1 RINL	4.21e-05	178	158	6	11c2ce093b7538518c8d4497dc5b0b4da22bf1a8
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL7A1 SHROOM3 LRRC10B RYR2 HEYL GUCY1A2	4.34e-05	179	158	6	f5bb4d3a27d56698473219970e764084096cc582
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL7A1 SHROOM3 LRRC10B RYR2 HEYL GUCY1A2	4.34e-05	179	158	6	fa03ec3cc0132f977b4cb28e7b23789732375183
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TNC HGSNAT OBSCN ITGA10 GRID1 GUCY1A2	4.34e-05	179	158	6	a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL7A1 SHROOM3 LRRC10B RYR2 HEYL GUCY1A2	4.48e-05	180	158	6	f6a05b3751b01e74b2de8440801b0eb2e723c199
ToppCell	droplet-Lung-nan-18m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL7A1 SHROOM3 LRRC10B RYR2 HEYL GUCY1A2	4.48e-05	180	158	6	dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LRRC75B CAND2 SHMT2 TIPARP HEYL GUCY1A2	4.62e-05	181	158	6	274c0b768925cd5804483303f8c5ebd17a534c41
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C GRID1 RYR2 HEYL GUCY1A2 CACNA1H	4.62e-05	181	158	6	451b87ac95154bb80018b8dd245b4a6389d81411
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	CACNA1C GRID1 HEYL GUCY1A2 SCN3A CACNA1H	4.62e-05	181	158	6	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C TNC GASK1B HEYL TENM4 GUCY1A2	4.76e-05	182	158	6	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	CACNA1C COL7A1 RYR3 TENM4 TRIB3 LGR6	4.76e-05	182	158	6	ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TNC GRID1 RYR2 TENM4 NALCN LRP1	4.91e-05	183	158	6	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C GRID1 RYR2 HEYL GUCY1A2 CACNA1H	5.21e-05	185	158	6	a7dba7db79275884b2a93d8a16f2e0c739e71370
Drug	CNS 1145	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	8.93e-08	33	156	6	CID000190902
Drug	IHC-64	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	8.93e-08	33	156	6	CID000162753
Drug	nilvadipine	CACNA1C CYP1A2 CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	1.76e-07	60	156	7	CID000004494
Drug	Dantrolene	CYP1A1 VIM CYP1A2 RYR2 RYR3 EIF2AK3	3.47e-07	41	156	6	ctd:D003620
Drug	isradipine	CACNA1C CYP1A2 CACNA1F CACNA2D2 RYR2 RYR3 SCN3A CACNA1H	4.43e-07	100	156	8	CID000003784
Drug	NSC7524	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 SCN2A SCN3A B3GAT1 CACNA1H EIF2AK3	5.32e-07	182	156	10	CID000005657
Drug	nisoldipine	CACNA1C CYP1A2 CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	1.09e-06	78	156	7	CID000004499
Drug	lamotrigine	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 SCN2A SCN3A CACNA1H	1.38e-06	116	156	8	CID000003878
Drug	Cinildipine	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	2.30e-06	56	156	6	CID000002752
Drug	bepridil	CACNA1C CACNA1F CACNA2D2 TNC RYR2 RYR3 SCN3A CACNA1H	2.57e-06	126	156	8	CID000002351
Drug	phenytoin	CACNA1C CYP1A2 CACNA1F COL7A1 CACNA2D2 RYR2 RYR3 SCN2A SCN3A CACNA1H	2.85e-06	219	156	10	CID000001775
Drug	riluzole	CACNA1C CYP1A2 CACNA1F CACNA2D2 GRID1 RYR2 RYR3 SCN3A CACNA1H	3.29e-06	174	156	9	CID000005070
Drug	IAA-94	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	3.82e-06	61	156	6	CID000003667
Drug	lercanidipine	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	4.62e-06	63	156	6	CID000065866
Drug	Zonisamide	SCN1A SCN2A SCN3A CACNA1H	4.71e-06	17	156	4	DB00909
Drug	fenpropathrin	CYP1A1 SCN2A SCN3A	6.22e-06	6	156	3	ctd:C044267
Drug	gallopamil	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	6.64e-06	67	156	6	CID000001234
Drug	AC1L2AC7	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	7.89e-06	69	156	6	CID000068733
Drug	Acetazolamide [59-66-5]; Down 200; 18uM; PC3; HT_HG-U133A	JMJD4 BCL3 SEMA4G CARD8 RIN1 AP5Z1 AK2 LRRC14 PC	9.79e-06	199	156	9	1808_DN
Drug	Isradipine	CACNA1C CACNA2D2 CACNA1H	1.08e-05	7	156	3	DB00270
Drug	CAS 298-57-7	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	1.10e-05	73	156	6	CID000002761
Drug	ethosuximide	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	1.19e-05	74	156	6	CID000003291
Drug	AC1NBU2S	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 GUCY1A2 CACNA1H	1.64e-05	117	156	7	CID004473765
Drug	Nitrendipine	CACNA1C CACNA2D2 CACNA1H	1.72e-05	8	156	3	DB01054
Drug	N-cyclopentyl-N-cyclobutylformamide	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	1.73e-05	79	156	6	CID005287890
Drug	gabapentin	CACNA1C CACNA1F CACNA2D2 GRID1 RYR2 RYR3 SCN3A CACNA1H	2.23e-05	169	156	8	CID000003446
Drug	felodipine	CACNA1C CYP1A1 CYP1A2 CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	2.23e-05	169	156	8	CID000003333
Drug	Cinnarizine	CACNA1C CACNA1F CACNA1H	2.57e-05	9	156	3	DB00568
Drug	pimozide	CACNA1C CYP1A2 CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	2.78e-05	127	156	7	CID000016362
Drug	PCB 95	CYP1A1 RYR2 RYR3	3.66e-05	10	156	3	CID000038012
Drug	cyclophorine	CACNA1C CYP1A2 CACNA1F COL7A1 EVC2 CACNA2D2 FPR3 KLK12 FKBP11 RYR2 RYR3 CACNA1H	3.92e-05	426	156	12	CID000002909
Drug	AC1L1DXE	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 NOXO1 PNPLA6 B3GAT1 CACNA1H EIF2AK3	4.26e-05	299	156	10	CID000002548
Drug	2-methoxy-4-aminoazobenzene	CYP1A1 CYP1A2	4.66e-05	2	156	2	ctd:C053767
Drug	3,4,3',4'-tetrachloroazoxybenzene	CYP1A1 CYP1A2	4.66e-05	2	156	2	ctd:C013280
Drug	cloflucarban	CYP1A1 CYP1A2	4.66e-05	2	156	2	ctd:C005055
Drug	musk xylene	CYP1A1 CYP1A2	4.66e-05	2	156	2	ctd:C031447
Drug	sesamex	CYP1A1 CYP1A2	4.66e-05	2	156	2	ctd:C100180
Drug	Canthaxanthin	CYP1A1 CYP1A2	4.66e-05	2	156	2	ctd:D016644
Drug	Pigment Yellow 74	CYP1A1 CYP1A2	4.66e-05	2	156	2	CID000022829
Drug	pyridoxal isonicotinoyl hydrazone	CYP1A1 CYP1A2	4.66e-05	2	156	2	ctd:C021079
Drug	nitroaniline	CYP1A1 CYP1A2	4.66e-05	2	156	2	ctd:C008625
Drug	7H-dibenzo(c,g)carbazole	CYP1A1 CYP1A2	4.66e-05	2	156	2	ctd:C013478
Drug	2,7-dinitrofluorene	CYP1A1 CYP1A2	4.66e-05	2	156	2	ctd:C085049
Drug	beta-apo-8'-carotenal	CYP1A1 CYP1A2	4.66e-05	2	156	2	ctd:C110652
Drug	propachlor	CYP1A1 CYP1A2	4.66e-05	2	156	2	ctd:C011088
Drug	allocryptopine	CYP1A1 CYP1A2	4.66e-05	2	156	2	ctd:C109505
Drug	2,7-FAA	CYP1A1 CYP1A2	4.66e-05	2	156	2	CID000009352
Drug	protopine	CYP1A1 CYP1A2	4.66e-05	2	156	2	ctd:C009093
Drug	manidipine	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	4.94e-05	95	156	6	CID000004008
Drug	Mibefradil	CACNA1C CACNA1F CACNA1H	5.00e-05	11	156	3	DB01388
Drug	Felodipine	CACNA1C CACNA2D2 CACNA1H	5.00e-05	11	156	3	DB01023
Drug	0317956-0000 [391210-11-0]; Up 200; 1uM; MCF7; HT_HG-U133A	CYP1A1 IL17RC PCDH12 SEMA4G RNF6 CPSF1 LRRC14 ZNF324B	5.53e-05	192	156	8	3858_UP
Drug	isotetrandrine	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	5.55e-05	97	156	6	CID000005422
Drug	nitrendipine	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	5.88e-05	98	156	6	CID000004507
Drug	AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A	NPHP1 COL7A1 TNC RYR3 SCN3A B3GAT1 CACNA1H LRRC14	6.39e-05	196	156	8	6435_UP
Drug	nicardipine	CACNA1C CYP1A2 CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	6.49e-05	145	156	7	CID000004473
Drug	Dantrolene-13C3	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 AK2 CACNA1H	6.49e-05	145	156	7	CID000002951
Drug	Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; PC3; HT_HG-U133A	CACNA2D2 ITGA10 IL17RC RYR2 AK2 DECR2 LRRC14 PC	6.87e-05	198	156	8	2123_DN
Drug	Pentoxifylline [6493-05-6]; Up 200; 14.4uM; PC3; HT_HG-U133A	EPPK1 CACNA2D2 SEMA4G RYR2 RNF6 AP5Z1 LRP1 TMEM231	7.11e-05	199	156	8	7319_UP
Drug	mibefradil	CACNA1C CYP1A2 CACNA2D2 RYR3 CACNA1H	7.79e-05	64	156	5	CID000060662
Drug	1,8-dinitropyrene	CYP1A1 CYP1A2 TIPARP	8.58e-05	13	156	3	ctd:C033310
Drug	loperamide	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 CACNA1H	8.65e-05	105	156	6	CID000003954
Drug	Verapamil	CACNA1C CYP1A1 VIM CYP1A2 CACNA1F CACNA1H	8.65e-05	105	156	6	ctd:D014700
Drug	BM-1	XCR1 BCL3 HAO1 TNFRSF1A ALG1	9.04e-05	66	156	5	CID000159986
Drug	procaine	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 SCN3A CACNA1H	9.10e-05	153	156	7	CID000004914
Drug	butylparaben	CACNA1C CYP1A1 CYP1A2 CACNA1F CACNA2D2 STXBP1 CACNA1H	1.07e-04	157	156	7	ctd:C038091
Drug	FPL 64176	CACNA1C RYR2 RYR3	1.35e-04	15	156	3	CID000003423
Drug	2,3-diaminotoluene	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:C100420
Drug	2-amino-1-methyl-6-phenyl-1H-imidazo(4,5-b)pyridine	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:C522525
Drug	2-amino-1,7-dimethylimidazo(4,5-g)quinoxaline	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:C519626
Drug	scutellarein	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:C458179
Drug	genkwanin	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:C014568
Drug	cis-diammineplatinum(II	RYR2 RYR3	1.39e-04	3	156	2	CID000159790
Drug	1-methoxyrutaecarpine	CYP1A1 CYP1A2	1.39e-04	3	156	2	CID005319487
Drug	2-hydroxyheptanoic acid	RYR2 RYR3	1.39e-04	3	156	2	CID002750949
Drug	Suppressor Factors, Immunologic	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:D013491
Drug	8N3-cADPR	RYR2 RYR3	1.39e-04	3	156	2	CID000127713
Drug	alyssin	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:C524316
Drug	2-oxohexyl isothiocyanate	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:C524315
Drug	aminodantrolene	RYR2 RYR3	1.39e-04	3	156	2	CID009570289
Drug	Trichloroepoxypropane	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:D014239
Drug	3-aminofluorene	CYP1A1 CYP1A2	1.39e-04	3	156	2	CID000022818
Drug	1-aminofluorene	CYP1A1 CYP1A2	1.39e-04	3	156	2	CID000022817
Drug	2,2',4,6'-tetramethoxystilbene	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:C541980
Drug	6-nitrobenzo(a)pyrene	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:C034699
Drug	chlortoluron	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:C007033
Drug	Aminoquinolines	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:D000634
Drug	2-hydroxycarbazole	RYR2 RYR3	1.39e-04	3	156	2	CID000093551
Drug	2,3,6,7-tetrachlorobiphenylene	CYP1A1 PC	1.39e-04	3	156	2	CID000081533
Drug	7-(deoxyadenosin-N(6)--yl)aristolactam II	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:C405699
Drug	1,2,3,7,8-pentachlorodibenzofuran	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:C057584
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR2 RYR3	1.39e-04	3	156	2	CID005748312
Drug	7-nitrobenzanthracene	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:C038954
Drug	1,2-dichloroethylene	CYP1A1 CYP1A2	1.39e-04	3	156	2	ctd:C035384
Drug	TCNB	VIM OBSCN RYR2 RYR3 MIB1 B3GAT1	1.72e-04	119	156	6	CID000008330
Drug	3,4',5-trimethoxystilbene	CYP1A1 VIM CYP1A2	2.00e-04	17	156	3	ctd:C497286
Drug	PD 150606	CYP1A1 SCN2A SCN3A	2.00e-04	17	156	3	ctd:C100442
Drug	papaverine	CACNA1C CACNA1F CACNA2D2 RYR2 RYR3 GUCY1A2 CACNA1H	2.17e-04	176	156	7	CID000004680
Drug	Isradipine	CYP1A1 CYP1A2 CACNA1F	2.39e-04	18	156	3	ctd:D017275
Drug	15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A	CYP1A1 TNC IL17RC BCL3 CPS1 LRRC14 PC	2.66e-04	182	156	7	1231_DN
Disease	Lung Injury	CYP1A1 CYP1A2 TNC TNFRSF1A	3.50e-06	21	149	4	C0273115
Disease	Chronic Lung Injury	CYP1A1 CYP1A2 TNC TNFRSF1A	3.50e-06	21	149	4	C2350344
Disease	alcohol use disorder (implicated_via_orthology)	KDM5B SHMT2 RIOX1 RYR2 RYR3 GIPR STXBP1 CTBP2	7.08e-06	195	149	8	DOID:1574 (implicated_via_orthology)
Disease	Hypertrophic Cardiomyopathy	CACNA1C OBSCN RYR2 ATAD3A ALPK3	1.04e-05	57	149	5	C0007194
Disease	generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology)	SCN1A SCN2A SCN3A	1.48e-05	10	149	3	DOID:0111294 (implicated_via_orthology)
Disease	Dravet syndrome (implicated_via_orthology)	SCN1A SCN2A SCN3A	1.48e-05	10	149	3	DOID:0080422 (implicated_via_orthology)
Disease	5-hydroxy-2-methylpyridine sulfate measurement	CYP1A1 CYP1A2	2.53e-05	2	149	2	EFO_0801051
Disease	serum clozapine measurement	CYP1A1 CYP1A2	2.53e-05	2	149	2	EFO_0600041
Disease	generalized epilepsy with febrile seizures plus (implicated_via_orthology)	SCN1A SCN2A SCN3A	2.68e-05	12	149	3	DOID:0060170 (implicated_via_orthology)
Disease	Infantile Severe Myoclonic Epilepsy	STXBP1 SCN1A SCN2A	3.48e-05	13	149	3	C0751122
Disease	pulmonary hypertension (biomarker_via_orthology)	CYP1A1 VIM TNC RYR2 RYR3	5.44e-05	80	149	5	DOID:6432 (biomarker_via_orthology)
Disease	Early infantile epileptic encephalopathy with suppression bursts	STXBP1 SCN1A SCN2A	6.73e-05	16	149	3	C0393706
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR2 RYR3	7.57e-05	3	149	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR2 RYR3	7.57e-05	3	149	2	DOID:8545 (implicated_via_orthology)
Disease	Hyperoxia	CYP1A1 TNFRSF1A	7.57e-05	3	149	2	C0242706
Disease	albuminuria	CYP1A1 CYP1A2 SHROOM3 CPS1 TMCO5B	1.17e-04	94	149	5	EFO_0004285
Disease	Motor Neuron Disease, Upper	VIM PNPLA6	1.51e-04	4	149	2	C0521659
Disease	Motor Neuron Disease, Secondary	VIM PNPLA6	1.51e-04	4	149	2	C0543858
Disease	Timothy syndrome (implicated_via_orthology)	CACNA1C CACNA1F	1.51e-04	4	149	2	DOID:0060173 (implicated_via_orthology)
Disease	Motor Neuron Disease	VIM PNPLA6	1.51e-04	4	149	2	C0085084
Disease	Familial Motor Neuron Disease	VIM PNPLA6	1.51e-04	4	149	2	C0270763
Disease	Motor Neuron Disease, Lower	VIM PNPLA6	1.51e-04	4	149	2	C0270764
Disease	X-21286 measurement	CYP1A1 CYP1A2	1.51e-04	4	149	2	EFO_0800804
Disease	Anterior Horn Cell Disease	VIM PNPLA6	1.51e-04	4	149	2	C0154681
Disease	neuromuscular disease (implicated_via_orthology)	ATAD3C ATAD3A	1.51e-04	4	149	2	DOID:440 (implicated_via_orthology)
Disease	sodium measurement	CYP1A1 CYP1A2 GIPR BTBD7 SCN2A	1.81e-04	103	149	5	EFO_0009282
Disease	anxiety disorder (implicated_via_orthology)	SCN1A SCN2A SCN3A	1.81e-04	22	149	3	DOID:2030 (implicated_via_orthology)
Disease	epilepsy (implicated_via_orthology)	CACNA2D2 SCN1A SCN2A SCN3A MIB1 LRP1	1.86e-04	163	149	6	DOID:1826 (implicated_via_orthology)
Disease	Epilepsy	CACNA2D2 PCDH12 STXBP1 SCN1A SCN2A	2.35e-04	109	149	5	C0014544
Disease	Lateral Sclerosis	VIM PNPLA6	2.51e-04	5	149	2	C0154682
Disease	response to trauma exposure, post-traumatic stress disorder symptom measurement	OR11L1 GRID1	2.51e-04	5	149	2	EFO_0008483, EFO_0008535
Disease	urinary potassium to creatinine ratio	CPS1 GIPR	3.75e-04	6	149	2	EFO_0009882
Disease	Epilepsy, Generalized	SCN1A CACNA1H	3.75e-04	6	149	2	C0014548
Disease	porphyria cutanea tarda (is_implicated_in)	CYP1A1 CYP1A2	3.75e-04	6	149	2	DOID:3132 (is_implicated_in)
Disease	Manic Disorder	CACNA1C TENM4 SCN2A PC	4.67e-04	71	149	4	C0024713
Disease	serum urea measurement	CYP1A1 CYP1A2 SHROOM3 CPS1 GIPR LGR6	4.84e-04	195	149	6	EFO_0009795
Disease	Seizure, Febrile, Simple	SCN1A SCN2A	5.23e-04	7	149	2	C0149886
Disease	Seizure, Febrile, Complex	SCN1A SCN2A	5.23e-04	7	149	2	C0751057
Disease	Akinetic Petit Mal	CACNA2D2 CACNA1H	5.23e-04	7	149	2	C0001890
Disease	Epilepsy, Absence, Atypical	CACNA2D2 CACNA1H	5.23e-04	7	149	2	C0751124
Disease	Absence Seizure Disorder	CACNA2D2 CACNA1H	5.23e-04	7	149	2	C4553705
Disease	Juvenile Absence Epilepsy	CACNA2D2 CACNA1H	5.23e-04	7	149	2	C4317339
Disease	Childhood Absence Epilepsy	CACNA2D2 CACNA1H	5.23e-04	7	149	2	C4281785
Disease	Epilepsy, Minor	CACNA2D2 CACNA1H	5.23e-04	7	149	2	C4552765
Disease	Absence Epilepsy	CACNA2D2 CACNA1H	5.23e-04	7	149	2	C0014553
Disease	non-small cell lung carcinoma	CYP1A1 CYP1A2 CPS1 NALCN	5.75e-04	75	149	4	EFO_0003060
Disease	Manic	CACNA1C TENM4 SCN2A PC	6.66e-04	78	149	4	C0338831
Disease	Early Childhood Epilepsy, Myoclonic	STXBP1 SCN1A	6.95e-04	8	149	2	C0393695
Disease	Idiopathic Myoclonic Epilepsy	STXBP1 SCN1A	6.95e-04	8	149	2	C0338478
Disease	Symptomatic Myoclonic Epilepsy	STXBP1 SCN1A	6.95e-04	8	149	2	C0338479
Disease	cerebellar ataxia (implicated_via_orthology)	PNPLA6 AARS2	6.95e-04	8	149	2	DOID:0050753 (implicated_via_orthology)
Disease	Benign Infantile Myoclonic Epilepsy	STXBP1 SCN1A	6.95e-04	8	149	2	C0751120
Disease	plasma clozapine measurement	CYP1A1 CYP1A2	6.95e-04	8	149	2	EFO_0600038
Disease	Myoclonic Encephalopathy	STXBP1 SCN1A	6.95e-04	8	149	2	C0438414
Disease	Myoclonic Absence Epilepsy	STXBP1 SCN1A	6.95e-04	8	149	2	C0393703
Disease	Depression, Bipolar	CACNA1C TENM4 SCN2A PC	6.99e-04	79	149	4	C0005587
Disease	bipolar I disorder	MYO1G CACNA1C CACNA2D2 TENM4 PC	7.65e-04	141	149	5	EFO_0009963
Disease	advanced glycation end-product measurement	CYP1A1 CYP1A2	8.91e-04	9	149	2	EFO_0007819
Disease	Febrile Convulsions	SCN1A SCN2A	8.91e-04	9	149	2	C0009952
Disease	response to 4'-epidoxorubicin, response to antineoplastic agent	ICE1 TNFRSF1A	8.91e-04	9	149	2	GO_0097327, GO_1902522
Disease	Myoclonic Epilepsy	STXBP1 SCN1A	8.91e-04	9	149	2	C0014550
Disease	Generalized Epilepsy with Febrile Seizures Plus	SCN1A SCN2A	8.91e-04	9	149	2	C3502809
Disease	parental longevity	GALNT15 SHROOM3 BICRA CPS1 RYR3 GUCY1A2 TCP11L2 AP5Z1 HTT	9.49e-04	494	149	9	EFO_0007796
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	SHROOM3 BCL3 GIPR MACF1 MTMR9 HTT	9.52e-04	222	149	6	EFO_0008317, EFO_0020943
Disease	theophylline measurement	CYP1A1 CYP1A2	1.11e-03	10	149	2	EFO_0021180
Disease	sweet beverage consumption measurement	CYP1A1 CYP1A2	1.11e-03	10	149	2	EFO_0010090
Disease	1,7-dimethylurate measurement	CYP1A1 CYP1A2	1.11e-03	10	149	2	EFO_0021512
Disease	Pleural Diseases	TNC CARD8	1.11e-03	10	149	2	C0032226
Disease	Epilepsy, Myoclonic, Infantile	STXBP1 SCN1A	1.11e-03	10	149	2	C0917800
Disease	1-methylxanthine measurement	CYP1A1 CYP1A2	1.35e-03	11	149	2	EFO_0021174
Disease	plasma N-desmethylclozapine measurement	CYP1A1 CYP1A2	1.35e-03	11	149	2	EFO_0600039
Disease	Shortened QT interval	CACNA1C LRP5	1.35e-03	11	149	2	C0151879
Disease	5-acetylamino-6-amino-3-methyluracil measurement	CYP1A1 CYP1A2	1.35e-03	11	149	2	EFO_0800951
Disease	Occupational Diseases	CYP1A1 CARD8	1.35e-03	11	149	2	C0028797
Disease	Myoclonic Astatic Epilepsy	STXBP1 SCN1A	1.35e-03	11	149	2	C0393702
Disease	Long QT Syndrome	CYP1A1 RYR2	1.35e-03	11	149	2	C0023976
Disease	comparative body size at age 10, self-reported	GRID1 AP3B1 FOCAD GIPR STXBP1 BTBD7 CTBP2 PPP6R3	1.37e-03	420	149	8	EFO_0009819
Disease	left ventricular systolic function measurement	OBSCN GIPR ALPK3	1.44e-03	44	149	3	EFO_0008206
Disease	paraxanthine measurement	CYP1A1 CYP1A2	1.62e-03	12	149	2	EFO_0021178
Disease	esophageal cancer (is_implicated_in)	CYP1A1 RNF6	1.90e-03	13	149	2	DOID:5041 (is_implicated_in)
Disease	ximenoylcarnitine (C26:1) measurement	LRP5 PPP6R3	1.90e-03	13	149	2	EFO_0800543
Disease	Bardet-Biedl Syndrome	NPHP1 BBS10	1.90e-03	13	149	2	C0752166
Disease	Intellectual Disability	TTI2 PCDH12 SCN1A PGAP2 SCN3A RLIM MACF1 HTT	2.03e-03	447	149	8	C3714756
Disease	Bardet-Biedl syndrome (is_implicated_in)	NPHP1 BBS10	2.21e-03	14	149	2	DOID:1935 (is_implicated_in)
Disease	eating disorder, bipolar disorder	RYR2 NALCN	2.21e-03	14	149	2	EFO_0005203, MONDO_0004985
Disease	extrinsic allergic alveolitis (is_marker_for)	TNC TNFRSF1A	2.21e-03	14	149	2	DOID:841 (is_marker_for)
Disease	generalised epilepsy	CACNA2D2 RYR2 SCN1A	2.33e-03	52	149	3	EFO_0005917
Disease	Ciliopathies	NPHP1 EVC2 BBS10 TMEM231	2.38e-03	110	149	4	C4277690
Disease	MMR-related febrile seizures	SCN1A SCN2A	2.55e-03	15	149	2	EFO_0006519
Disease	1,3,7-trimethylurate measurement	CYP1A1 CYP1A2	2.55e-03	15	149	2	EFO_0021172
Disease	Peripheral Nervous System Diseases	DPYD PNPLA6 CACNA1H	2.59e-03	54	149	3	C4721453
Disease	coffee consumption, cups of coffee per day measurement	CYP1A1 CYP1A2	2.90e-03	16	149	2	EFO_0004330, EFO_0006782
Disease	Colorectal Neoplasms	CYP1A2 DPYD COL7A1 GRID1 GUCY1A2 LGR6	2.91e-03	277	149	6	C0009404
Disease	Polydactyly	EVC2 BBS10 PNPLA6 TMEM231	2.98e-03	117	149	4	C0152427
Disease	Colorectal Carcinoma	CYP1A2 DPYD COL7A1 EVC2 OBSCN GRID1 ARAP3 GUCY1A2 LRP1 LGR6	3.09e-03	702	149	10	C0009402
Disease	syndrome (implicated_via_orthology)	ATAD3C ATAD3A	3.67e-03	18	149	2	DOID:225 (implicated_via_orthology)
Disease	Febrile seizure (within the age range of 3 months to 6 years)	SCN1A SCN2A	3.67e-03	18	149	2	HP_0002373
Disease	Sjogren's syndrome (is_implicated_in)	CYP1A1 VIM	3.67e-03	18	149	2	DOID:12894 (is_implicated_in)
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	BCL3 CPS1 TENM4 MACF1 MTMR9 HTT	3.70e-03	291	149	6	EFO_0008317, EFO_0020946
Disease	caffeine metabolite measurement	CYP1A1 CYP1A2	4.09e-03	19	149	2	EFO_0007872

Protein segments in the cluster

Peptide	Gene	Start	Entry
RTPLTARLLRDTGLN	B3GAT1	126	Q9P2W7
GTRVSLTIRRVPRVL	ALKBH6	216	Q3KRA9
LTIRRVPRVLRAGLL	ALKBH6	221	Q3KRA9
EGRLRDPATITTLRV	PPP2R2B	136	Q00005
GSGLVTRLRERPALL	ALG1	266	Q9BT22
LFTGIRRESPRVGLL	ARAP3	1216	Q8WWN8
IRRAITGRIPESLRN	CTBP2	341	P56545
TAVELSLGRRTLRPA	CACNA2D2	826	Q9NY47
TELRPRGRSLVIIST	EIF2AK3	96	Q9NZJ5
RGRSLVIISTLDGRI	EIF2AK3	101	Q9NZJ5
GLRIVELTLPRVSVR	BPIFB4	226	P59827
LLPVTSRTRIRRSGV	ASB2	356	Q96Q27
RLGKPSLVRETSRIT	ATAD3A	326	Q9NVI7
ALVTRISILLRDLPT	FAM174B	76	Q3ZCQ3
AGLSPRTSRRILERV	ALPK3	1206	Q96L96
RPIALRAVTSIARAL	DPYD	771	Q12882
RLRLARSTLTLVPLL	GIPR	336	P48546
LRADRIEGILTRFLP	AP5S1	161	Q9NUS5
ALPLALRTVSRLVER	AP5Z1	786	O43299
LPLRVSTRRRGSLEE	CD163L1	1391	Q9NR16
SEEVSLIRRIIGLSP	BBS10	336	Q8TAM1
IRASALRVLSSIRVP	AP3B1	131	O00203
IRASALRVLSSIRVP	AP3B2	126	Q13367
LRQRLVLSTLSGRPV	RCL1	16	Q9Y2P8
ELDTVIGRSRRPRLS	CYP1A1	346	P04798
GSTPVLVLSRLDTIR	CYP1A2	81	P05177
GTLRSLRPILNTLLE	TIPARP	51	Q7Z3E1
LTARLFRPRLIIAGT	SHMT2	211	P34897
SGPRQILRSLVRLSV	PCDH12	926	Q9NPG4
APLVRLLRISTIAEG	ANKAR	1036	Q7Z5J8
AEVGLRLVRLRLDTP	CES1P1	266	Q9UKY3
RLVRLRLDTPTSLAL	CES1P1	271	Q9UKY3
PVRSGTARILIILVD	PCDHGA4	251	Q9Y5G9
RAFRVLRPLRLVSGV	CACNA1F	206	O60840
LTKLSLITAPRRERG	MISP	331	Q8IVT2
LPLDRDGTLVRLRFT	PGAP2	6	Q9UHJ9
GPTLLLNSDIIRARL	PNPLA6	811	Q8IY17
AEESRRSTPVGRLLL	GJC3	11	Q8NFK1
ERLVSLEPVISVRSR	C22orf46	201	C9J442
TRRQLGLVPREKSVT	NUP98	1111	P52948
LLRLRLPVRVTSSVQ	KLK12	111	Q9UKR0
LAQIILEPRSRTIRG	MTMR9	346	Q96QG7
LEPRSRTIRGFEALI	MTMR9	351	Q96QG7
EILTLTRAGIRLLPS	LGR6	331	Q9HBX8
RTVLVSSGLREPRAL	LRP1	3136	Q07954
ATPRSLLSQVRLVVR	ASB12	266	Q8WXK4
PDSLLIRRITGRLIH	AK2	131	P54819
ERLIRSLPTSLERAL	FPR3	311	P25089
LARRTDLRRISLDTP	LRP5	346	O75197
RLLGERLTPREISEV	CABP5	136	Q9NP86
LLSRIAGDRSRVVSP	GALNT15	296	Q8N3T1
SPRLAVRKRTIIALG	CAND1	186	Q86VP6
GTRLVVLPFRRESLA	CPSF1	156	Q10570
VIQVLRRSPRLRGDS	PDZD4	46	Q76G19
RRLTSLPIVAKGILR	HAO1	226	Q9UJM8
VIASRSLPRVLTAAR	DECR2	56	Q9NUI1
SLVTRLLLAPRRGLT	DDX28	11	Q9NUL7
IRASSPRVLLTVLAR	PDZD3	181	Q86UT5
GATLRRLLSVVLPTA	EVC2	1136	Q86UK5
VGLRRRLSQRTSLPT	LRRC75B	261	Q2VPJ9
LLKDIRSVLEPTRGR	METTL9	221	Q9H1A3
RSVLEPTRGRVILAL	METTL9	226	Q9H1A3
ALRTAPLRRATGIIL	HEYL	216	Q9NQ87
LELSGRRLRRLPSAV	LRRC10B	26	A6NIK2
LDTLIELVTRGRSIP	KDM5B	1036	Q9UGL1
ALLVTTRPRALRDLR	NLRP2	331	Q9NX02
PLISRRDAEVVLTSR	TWNK	251	Q96RR1
IVSSILRIPSTSGRR	OR11L1	221	Q8NGX0
RGSPALSREALVRVL	PCDHB10	536	Q9UN67
VAVRRLGRQESPLSL	MAST1	1326	Q9Y2H9
LISRLTESRGPLSVV	MACF1	1626	Q9UPN3
RITTPGSERVLLESR	MIB1	126	Q86YT6
TLSEPRSGLLVLVIR	OBSCN	6156	Q5VST9
RGSPALSREALVRVL	PCDHB16	536	Q9NRJ7
PRSGTALVRILVLDV	PCDHB7	221	Q9Y5E2
IIAAILRIPTSRGRH	OR6P1	221	Q8NGX9
RPVSSRSGARLLVLE	GASK1B	236	Q6UWH4
VIRRTAVDSGIPLLT	CPS1	1451	P31327
IDRRAVPARVSLGIT	GABRR3	291	A8MPY1
GRIIDTSLTRDPLVI	FKBP11	71	Q9NYL4
RTPAILISEVVRSLL	HTT	2691	P42858
TPDIIIASILRLIGR	ICE1	2161	Q9Y2F5
LRAFRVLRPLRLVSG	CACNA1C	236	Q13936
RSRLPVSLSEGRLRV	FCGBP	556	Q9Y6R7
LSSGVNLPARRVIIR	POLQ	446	O75417
GALRLLVPRLVLTVS	JMJD4	16	Q9H9V9
ILLRIASGTRLSIPI	CARD8	301	Q9Y2G2
VGILRRILRTLRDFP	ANKRD9	126	Q96BM1
ARLGKPSLVRETSRI	ATAD3C	101	Q5T2N8
EITDRTLRTPTRIIL	BTBD7	301	Q9P203
RLSPRRLRLSVGNVT	ITGA10	721	O75578
LRTSIGERKRSLSPL	HAUS6	896	Q7Z4H7
RDTLRRAILLLSPQG	GRID1	221	Q9ULK0
PRLRSVDTFRGIALI	HGSNAT	266	Q68CP4
ATRRVLERLVLALGP	COL7A1	1071	Q02388
PRGSTARTLLRLLLR	SDR42E2	381	A6NKP2
VRTIARDSLARIPLL	FLRT1	111	Q9NZU1
TIEPTSGIVRTVRRL	CELSR3	1011	Q9NYQ7
ASGRGLLPLVRTLVR	BCL3	316	P20749
RLLLLEESRRVSPSA	BICRA	1156	Q9NZM4
SAIRTVRVLRPLRAI	CACNA1H	196	O95180
EVSGPVLSELLRLLR	CAND2	731	O75155
AIRIRSILRSLIPLG	RYR2	2416	Q92736
TARTGLPRKTRIILE	MENT	51	Q9BUN1
ILRIIQLLGTTPRLR	FOCAD	526	Q5VW36
QLLGTTPRLRAVTLR	FOCAD	531	Q5VW36
TPRLRAVTLRLLTSL	FOCAD	536	Q5VW36
ALGRSPVVLSLERLV	IL17RC	11	Q8NAC3
EGTIRSRPSRISLIL	NPHP1	371	O15259
LEGNPLRTIRREIIS	LRRC40	341	Q9H9A6
LSPLVRLQELRLSGA	LINGO4	296	Q6UY18
TRDLVVRLPRLLTGS	MTERF3	276	Q96E29
LRISTRRPETLGELQ	NOXRED1	106	Q6NXP6
ILRTILKIPSAEGRR	OR10R2	241	Q8NGX6
ERVLLRLSTPFVIRT	GUCY1A2	376	P33402
LLRTRARIPGALQIT	RTL6	66	Q6ICC9
TPGRLPSIRSRDLTL	POLR3D	36	P05423
RPGRVVSLRERLLLT	RIN1	51	Q13671
VLPLVLSRGTLESLR	TMCO5B	276	A8MYB1
ITGGLPELASRLTRI	TCP11L2	356	Q8N4U5
LSLLPLVRRARGRVV	RDH16	146	O75452
PSIRLIFRRLSLGRI	OR5AU1	11	Q8NGC0
TLDLPALTRRLTAII	EPPK1	2561	P58107
TITLDLQVRRIRPGE	RNF6	396	Q9Y252
TPISNTGILELRRVR	SIGLEC5	291	O15389
TPGRISLRISESVLR	SHROOM3	1481	Q8TF72
ILATVLRAPTAAERR	OR6T1	221	Q8NGN1
SPTLFRVIRLARIGR	SCN3A	1616	Q9NY46
RRVGIPRVILSASIT	TMEM150C	161	B9EJG8
LGVPIVTDSTLRRRS	STXBP1	446	P61764
RLLATAERVARSPTI	NOXO1	106	Q8NFA2
RRIIDRTLRTLGPSD	AARS2	416	Q5JTZ9
SGSVLALPLRSRKIR	RIOX1	26	Q9H6W3
VSPQLTLRALRERLG	SPATA1	71	Q5VX52
SPTLFRVIRLARIGR	SCN1A	1631	P35498
ALARRVSLLRPLSRV	CHPF2	461	Q9P2E5
RSLGLLPALRLETVD	INPP5J	956	Q15735
LGVLSTLEPLTRLQR	RINL	31	Q6ZS11
STLRVPTLRCRVLVT	XCR1	136	P46094
GLSTSRPRVVIQLER	ZNF324	41	O75467
ELTNGLVALPSRLRR	SEMA4G	776	Q9NTN9
ELDGTILKSRPLRIR	PSPC1	136	Q8WXF1
LTDARIRRLLPSLIG	RSL1D1	156	O76021
PRSREVAREVLTSLL	TTI2	166	Q6NXR4
GEAIRIRSILRSLVP	RYR3	2311	Q15413
LRREPAERLTATGIL	TRIB3	296	Q96RU7
TIRIPIRRILNTGLS	RLIM	381	Q9NVW2
SPTLFRVIRLARIGR	SCN2A	1621	Q99250
ITLLAPERTRDITGL	TNC	1666	P24821
SAVRLRSSVPGVRLL	VIM	66	P08670
VALLELAGPVRRSRL	TMPRSS9	916	Q7Z410
RLLTQEARSLEGTPR	TENM4	501	Q6N022
ETPINRLSLLLSGRV	POPDC2	151	Q9HBU9
IRSLSLIRLEGVEGR	RFPL2	36	O75678
ISRLQPRVRILVDGS	IGSF9	271	Q9P2J2
PRVRILVDGSLRLLA	IGSF9	276	Q9P2J2
ATPGARLLLRITKRT	ZC3H11B	501	A0A1B0GTU1
LVALVRASITDPGRL	ZDHHC21	61	Q8IVQ6
LTGTVTLELRRAPRL	TMEM253	76	P0C7T8
RLQGDRLRVPLVSTR	TMEM231	91	Q9H6L2
PARELLTDIRSTLIR	TRIM10	246	Q9UDY6
ILILQLPSTRGGRRS	nan	106	Q6ZS52
ILLTLLETRRPTFEG	PPP6R3	271	Q5H9R7
TPRREATLELLGRVL	TNFRSF1A	411	P19438
LRLLGIRRTSTAPAA	PC	11	P11498
GLSTSRPRVVIQLER	ZNF324B	41	Q6AW86
AIAEIRRLRPGSIET	DUSP23	121	Q9BVJ7
LREALRSSVGSPLRL	LRRC14	181	Q15048
ELPRTRITNILKRSG	NALCN	161	Q8IZF0
ATPRDLVLRSLLART	MYO1G	316	B0I1T2
PRTLVTLEQSRARLI	MYO1G	696	B0I1T2